Evidence map›Paper›PMID 40003994›Full record

ReviewInternational journal of molecular sciences2025

The PACT Network: PRL, ARL, CNNM, and TRPM Proteins in Magnesium Transport and Disease.

Jeffery T Jolly, Jessica S Blackburn

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Unlocking TRPM7 interactions: A database-driven quest.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffery T JollyDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0002-6748-3591
Jessica S BlackburnDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA.

Funding

The Phosphatase PRL3 as a MYC Target and Pro-Survival Oncogene in Acute Lymphoblastic LeukemiaR37CA227656 · NCI · UNIVERSITY OF KENTUCKY · PI BLACKBURN, JESSICA S. · 2018 to 2024
$2.4M
NCI NIH HHS 5R37CA227656NCI NIH HHS R37 CA227656
6 · The paper itself

Abstract

Magnesium, the most abundant divalent metal within the cell, is essential for physiological function and critical in cellular signaling. To maintain cellular homeostasis, intracellular magnesium levels are tightly regulated, as dysregulation is linked to numerous diseases, including cancer, diabetes, cardiovascular disorders, and neurological conditions. Over the past two decades, extensive research on magnesium-regulating proteins has provided valuable insight into their pathogenic and therapeutic potential. This review explores an emerging mechanism of magnesium homeostasis involving proteins in the PRL (phosphatase of regenerating liver), ARL (ADP ribosylation factor-like GTPase family), CNNM (cyclin and cystathionine β-synthase domain magnesium transport mediator), and TRPM (transient receptor potential melastatin) families, collectively termed herein as the PACT network. While each PACT protein has been studied within its individual signaling and disease contexts, their interactions suggest a broader regulatory network with therapeutic potential. This review consolidates the current knowledge on the PACT proteins' structure, function, and interactions and identifies research gaps to encourage future investigation. As the field of magnesium homeostasis continues to advance, understanding PACT protein interactions offers new opportunities for basic research and therapeutic development targeting magnesium-related disorders.

Indexed as

Cation Transport ProteinsMagnesiumTRPM Cation ChannelsAnimalsHomeostasisHumansSignal TransductionCation Transport ProteinsMagnesiumTRPM Cation ChannelscancerCBS-domainchannelopathiesion transportmetal homeostasisphosphatase of regenerating liverPTP4A3therapeutic development

Identifiers

PMID40003994
PMCPMC11855589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.